[59] Clarkson TW, Magos L, Myers GJ
Keywords: peptide, immune tolerance, lupus, regulatory T cells, immunotherapy, cytokine, chemokine Introduction Autoimmune rheumatic diseases carry a significant burden of morbidity and mortality and have a substantial economic impact on both individuals and the society as a whole
Category 3 preparations are produced in ISO-classified cleanroom environments with extensive environmental monitoring, personnel qualification, and process validation
Human clinical evidence Cerebrolysin has been used clinically in some countries for decades, primarily for stroke recovery, dementia, and traumatic brain injury
Please consult with a licensed medical provider to determine if peptide therapy is appropriate for you.